Citadel Advisors’s GMO Ultra-Short Income ETF GMOC Stock Holding History

Citadel Advisors’s Portfolio GMOC Stock Details GMOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$977K	Buy	19,518 +9,858	+102%	+$494K	﹤0.01%	8255
2026 Q1	$483K	Sell	9,660 -1,599	-14%	-$80.1K	﹤0.01%	9398
2025 Q4	$563K	Buy	+11,259	New	+$564K	﹤0.01%	8738

Other funds holding GMOC

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BPWM

BCS Private Wealth Management Rumson, New Jersey $332M AUM 23.51% 1-Year Est. Return

Citadel Advisors's GMOC Position: Q2 2026 in Review

Citadel Advisors increased its GMO Ultra-Short Income ETF (GMOC) stake by 102% in Q2 2026, buying an estimated $494K and bringing the position to 19,518 shares worth $977K. The position accounts for ﹤0.01% of the portfolio, ranked #8255.

Citadel Advisors first reported a position in GMOC in Q4 2025 and has held it in 3 quarters since. 6 funds tracked by Wall St. Rank hold GMOC as of Q2 2026.

Citadel Advisors held 19,518 shares of GMO Ultra-Short Income ETF worth $977K as of Q2 2026.
Citadel Advisors bought 9,858 GMO Ultra-Short Income ETF shares in Q2 2026, an estimated $494K.
GMO Ultra-Short Income ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8255 holding.
Citadel Advisors first reported a position in GMO Ultra-Short Income ETF in Q4 2025 and has held it in 3 quarters since.
6 funds tracked by Wall St. Rank held GMO Ultra-Short Income ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.